Pharmagreen Biotech (PHBI) Stock Statistics & Valuation Metrics

Pharmagreen Biotech has a market cap or net worth of $622.21K. The enterprise value is $722.72K.

Pharmagreen Biotech has 691,345,760 shares outstanding. The number of shares has decreased by -2.65% in one year.

Pharmagreen Biotech’s return on equity (ROE) is -0.15 and return on invested capital (ROIC) is 12.51%.

The current PE Ratio of Pharmagreen Biotech is ―. Pharmagreen Biotech’s PEG ratio is -0.03.

In the last 12 months, Pharmagreen Biotech had revenue of 2.39K and earned 406.36K in profits. Earnings per share was <0.01.

In the last 12 months, operating cash flow was -23.30K and capital expenditures -3.00, giving a free cash flow of -23.31K billion.

Pharmagreen Biotech pays an annual dividend of ―, resulting in a dividend yield of ―

Pharmagreen Biotech upcoming earnings date is Dec 19, 2025, TBA (Confirmed).

Pharmagreen Biotech as a current ratio of <0.01, with Debt / Equity ratio of -2.83%

In the past 12 months, Pharmagreen Biotech has paid 0.00 in taxes.

Pharmagreen Biotech EV to EBITDA ratio is -3.51, with an EV/FCF ratio of -43.71.

Pharmagreen Biotech has $721.00 in cash and marketable securities with $355.59K in debt, giving a net cash position of -$354.87K billion.

Gross margin is -0.02%, with operating margin of -12164.70%, and net profit margin of 17016.88%.

The average price target for Pharmagreen Biotech is ―, which is 11.43% higher than the current price. The consensus rating is ―